Form 8-K - Current report:
SEC Accession No. 0001193125-12-247355
Filing Date
2012-05-24
Accepted
2012-05-24 17:29:59
Documents
3
Period of Report
2012-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d358671d8k.htm 8-K 21390
2 EX-10.30 d358671dex1030.htm EX-10.30 217897
3 GRAPHIC g358671g32f02.jpg GRAPHIC 7055
  Complete submission text file 0001193125-12-247355.txt   250377
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 12868616
SIC: 2834 Pharmaceutical Preparations